T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
SGHC Ltd
SGHC
$6.57B
| $155K | ﹤0.01% |
47,808
+8,696
| +22% | +$28.2K |
|
2652
Aclaris Therapeutics
ACRS
$221M
| $154K | ﹤0.01% |
139,400
+29,633
| +27% | +$32.7K |
|
2653
GrowGeneration
GRWG
$89.1M
| $154K | ﹤0.01% |
71,385
+2,281
| +3% | +$4.92K |
|
2654
Altimmune
ALT
$324M
| $151K | ﹤0.01% |
22,668
+7,430
| +49% | +$49.5K |
|
2655
Gevo
GEVO
$392M
| $151K | ﹤0.01% |
273,900
-68,036
| -20% | -$37.5K |
|
2656
Kopin
KOPN
$344M
| $151K | ﹤0.01% |
179,700
+37,900
| +27% | +$31.8K |
|
|
NAGE
2657
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $151K | ﹤0.01% |
55,108
+15,808
| +40% | +$43.3K |
|
2658
Marine Products Corp
MPX
$317M
| $149K | ﹤0.01% |
14,668
+1,035
| +8% | +$10.5K |
|
2659
SmartRent
SMRT
$269M
| $148K | ﹤0.01% |
61,814
+8,637
| +16% | +$20.7K |
|
2660
The Beauty Health Co
SKIN
$292M
| $147K | ﹤0.01% |
76,447
+1,166
| +2% | +$2.24K |
|
2661
HilleVax
HLVX
$106M
| $146K | ﹤0.01% |
+10,063
| New | +$146K |
|
2662
Zymeworks
ZYME
$1.15B
| $146K | ﹤0.01% |
17,069
+1,405
| +9% | +$12K |
|
2663
Farmers National Banc Corp
FMNB
$562M
| $145K | ﹤0.01% |
11,551
+1,120
| +11% | +$14.1K |
|
|
PTVE
2664
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $145K | ﹤0.01% |
12,761
+1,317
| +12% | +$15K |
|
2665
Vivid Seats
SEAT
$96.5M
| $144K | ﹤0.01% |
1,248
+183
| +17% | +$21.1K |
|
|
VERV
2666
DELISTED
Verve Therapeutics
VERV
| $144K | ﹤0.01% |
29,314
+3,948
| +16% | +$19.4K |
|
2667
GoodRx Holdings
GDRX
$1.43B
| $143K | ﹤0.01% |
18,300
+4,000
| +28% | +$31.3K |
|
|
AGS
2668
DELISTED
PlayAGS
AGS
| $143K | ﹤0.01% |
12,391
+1,764
| +17% | +$20.4K |
|
2669
NewtekOne
NEWT
$305M
| $143K | ﹤0.01% |
+11,292
| New | +$143K |
|
2670
Omeros
OMER
$291M
| $143K | ﹤0.01% |
35,181
| – | – |
|
2671
Organogenesis Holdings
ORGO
$617M
| $143K | ﹤0.01% |
50,951
| – | – |
|
2672
Mission Produce
AVO
$829M
| $142K | ﹤0.01% |
14,317
+385
| +3% | +$3.82K |
|
2673
Pixelworks
PXLW
$61.5M
| $142K | ﹤0.01% |
12,033
+2,741
| +29% | +$32.3K |
|
|
OSG
2674
DELISTED
Overseas Shipholding Group Inc.
OSG
| $142K | ﹤0.01% |
16,641
-379
| -2% | -$3.23K |
|
2675
HarborOne Bancorp
HONE
$551M
| $140K | ﹤0.01% |
12,525
+744
| +6% | +$8.32K |
|